🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 18 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 23/10/2001 | 47,01 | 48,88 | 46,82 | 47,91 | +1,67% | 4,38% | 127.251 |
| 22/10/2001 | 43,53 | 47,24 | 42,89 | 47,12 | +6,69% | 9,97% | 62.437 |
| 19/10/2001 | 43,68 | 44,35 | 41,92 | 44,17 | +2,97% | 5,57% | 38.899 |
| 18/10/2001 | 40,05 | 43,61 | 40,01 | 42,89 | +5,43% | 8,97% | 149.052 |
| 17/10/2001 | 46,60 | 46,68 | 40,42 | 40,69 | -11,27% | 13,41% | 203.875 |
| 16/10/2001 | 44,92 | 46,49 | 43,91 | 45,85 | +6,24% | 5,75% | 179.963 |
| 15/10/2001 | 41,14 | 43,34 | 40,24 | 43,16 | +5,30% | 7,55% | 150.201 |
| 12/10/2001 | 38,55 | 41,17 | 38,55 | 40,99 | +4,19% | 6,80% | 35.106 |
| 11/10/2001 | 44,02 | 44,80 | 39,11 | 39,34 | -3,13% | 12,93% | 155.785 |
| 10/10/2001 | 36,16 | 41,14 | 35,93 | 40,61 | +9,60% | 14,39% | 620.628 |
| 09/10/2001 | 34,51 | 37,06 | 34,32 | 37,06 | +7,03% | 7,92% | 364.095 |
| 08/10/2001 | 35,18 | 36,12 | 34,25 | 34,62 | -3,14% | 5,32% | 16.511 |
| 05/10/2001 | 35,03 | 35,75 | 33,95 | 35,75 | +3,24% | 5,13% | 31.526 |
| 04/10/2001 | 37,28 | 37,62 | 33,76 | 34,62 | -7,04% | 10,34% | 43.869 |
| 03/10/2001 | 35,37 | 37,24 | 35,11 | 37,24 | +4,63% | 6,03% | 31.766 |
| 02/10/2001 | 34,62 | 37,02 | 34,44 | 35,60 | +2,04% | 7,46% | 53.647 |
| 01/10/2001 | 34,44 | 34,88 | 32,68 | 34,88 | +1,53% | 6,41% | 121.561 |
| 28/09/2001 | 31,70 | 35,52 | 31,70 | 34,36 | +8,25% | 12,04% | 89.741 |
| 27/09/2001 | 30,88 | 31,74 | 29,94 | 31,74 | +3,79% | 5,82% | 138.472 |
| 26/09/2001 | 31,74 | 33,87 | 30,51 | 30,58 | -0,49% | 10,61% | 222.630 |
| 25/09/2001 | 30,13 | 32,53 | 29,94 | 30,73 | +3,53% | 8,57% | 42.854 |
| 24/09/2001 | 30,95 | 32,00 | 28,26 | 29,68 | +1,02% | 12,09% | 86.108 |
| 21/09/2001 | 28,30 | 31,55 | 27,32 | 29,38 | -2,61% | 14,95% | 149.213 |
| 20/09/2001 | 29,91 | 31,07 | 29,87 | 30,17 | -3,47% | 4,00% | 117.286 |
| 19/09/2001 | 32,23 | 32,94 | 29,05 | 31,25 | -4,90% | 12,08% | 87.871 |
| 18/09/2001 | 32,98 | 34,25 | 32,56 | 32,86 | -6,79% | 5,11% | 57.281 |
| 17/09/2001 | 32,79 | 35,78 | 31,82 | 35,26 | +1,18% | 12,10% | 60.834 |
| 10/09/2001 | 35,37 | 35,67 | 33,50 | 34,85 | -2,51% | 6,14% | 36.148 |
| 07/09/2001 | 35,86 | 36,64 | 34,10 | 35,75 | -1,95% | 7,10% | 37.964 |
| 06/09/2001 | 36,64 | 37,54 | 35,37 | 36,46 | -1,81% | 5,92% | 32.033 |